Target intelligence / Profile preview

D-lactate dehydrogenase (quinone) (D-iLDH)

Target
D-iLDH
Molecular classification
Enzyme, Oxidoreductase, Flavoenzyme, Peripheral membrane protein
01

Overview

Bacterial membrane-bound D-lactate dehydrogenase (D-iLDH), specifically the quinone-dependent form (EC 1.1.5.12), is a flavoprotein essential for the utilization of D-lactate as a primary carbon and energy source in many bacteria (UniProt: P00361). It is located on the cytoplasmic surface of the inner membrane and facilitates the oxidation of D-lactate to pyruvate, transferring electrons directly to the respiratory quinone pool (PubMed: 15686558). This process is vital for maintaining the proton motive force and ATP production in pathogens like Escherichia coli and Staphylococcus aureus (PubMed: 28844881). Since humans primarily utilize L-lactate and possess a structurally distinct mitochondrial D-lactate dehydrogenase, this bacterial enzyme represents a promising target for narrow-spectrum antibiotics (PubMed: 31265111). Inhibiting D-iLDH can effectively starve bacteria of energy in lactate-rich environments, such as abscesses or the gut (PubMed: 25631484). Current therapeutic research focuses on small-molecule inhibitors that can selectively bind the bacterial enzyme's active site without cross-reacting with human metabolic pathways (PubMed: 18439557).

Other names
Bacterial membrane-bound D-lactate dehydrogenaseD-lactate:quinone oxidoreductaseD-LDHD-lactate ferricytochrome c oxidoreductasedld
02

Mechanism of action

Inhibition of the oxidation of D-lactate to pyruvate, which prevents electron transfer to the quinone pool, thereby disrupting the bacterial respiratory chain and ATP generation (PubMed: 28844881).

03

Biological functions

Lactate metabolismElectron transport chainEnergy productionCellular respiration
04

Disease associations

Bacterial infectionSepsisGastrointestinal dysbiosis
05

Safety considerations

Selectivity against human mitochondrial D-lactate dehydrogenaseImpact on beneficial gut microbiotaPotential for metabolic acidosis if D-lactate clearance is impaired
06

Interacting drugs

Oxalate

3 more in the full profile.

07

Biomarkers

Serum D-lactateUrinary D-lactate

Beyond the preview

Go deeper on D-lactate dehydrogenase (quinone) (D-iLDH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-lactate dehydrogenase (quinone) (D-iLDH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call